NM_000152.5:c.2495_2496delCA
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000152.5(GAA):c.2495_2496delCA(p.Thr832AsnfsTer51) variant causes a frameshift change. The variant allele was found at a frequency of 0.000000685 in 1,460,774 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T832T) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000152.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IIInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P
- glycogen storage disease due to acid maltase deficiency, infantile onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- glycogen storage disease due to acid maltase deficiency, late-onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | NM_000152.5 | MANE Select | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 18 of 20 | NP_000143.2 | ||
| GAA | NM_001079803.3 | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 19 of 21 | NP_001073271.1 | |||
| GAA | NM_001079804.3 | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 18 of 20 | NP_001073272.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAA | ENST00000302262.8 | TSL:1 MANE Select | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 18 of 20 | ENSP00000305692.3 | ||
| GAA | ENST00000390015.7 | TSL:1 | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 19 of 21 | ENSP00000374665.3 | ||
| GAA | ENST00000570803.6 | TSL:5 | c.2495_2496delCA | p.Thr832AsnfsTer51 | frameshift | Exon 18 of 20 | ENSP00000460543.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460774Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 726682 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Glycogen storage disease, type II Pathogenic:3
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
This sequence change creates a premature translational stop signal (p.Thr832Asnfs*51) in the GAA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAA are known to be pathogenic (PMID: 18425781, 22252923). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Pompe disease (PMID: 22644586, 25741864, 31342611). ClinVar contains an entry for this variant (Variation ID: 370706). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at